Thrombocytopenia in a surgical ICU

被引:193
作者
Stéphan, F
Hollande, J
Richard, O
Cheffi, A
Maier-Redelsperger, M
Flahault, A
机构
[1] Hop Tenon, Serv Anesthesie Reanimat Chirurg, F-75970 Paris, France
[2] Hop Tenon, Hematol Lab, F-75970 Paris, France
[3] Hop Tenon, Antenne Biostat & Informat Med, F-75970 Paris, France
关键词
disseminated intravascular coagulation; hemophagocytic histiocytes; ICU; platelet-associated IgG; sepsis; thrombocytopenia;
D O I
10.1378/chest.115.5.1363
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To assess the incidence of thrombocytopenia in surgical ICU patients, the factors associated with thrombocytopenia, the outcome of thrombocytopenic patients, and the possible mechanisms involved. Design: Prospective study. Setting: An 8-bed surgical ICU in an 885-bed teaching hospital, Patients: 147 consecutive patients admitted to the surgical ICU during a 6-month period, Main outcome measures: Incidence of thrombocytopenia (defined by a platelet count < 100,000/mm(3)), risk factors for thrombocytopenia, or death in thrombocytopenic patients identified by a stepwise logistic regression analysis, as well as the mechanisms involved, Results: Thrombocytopenia occurred in 52 patients (35%) with a mortality rate of 38%, compared with a 20%mortality rate in nonthrombocytopenic patients (p = 0.02). Sepsis, episodes of bleeding or transfusions, and an acute physiology and chronic health evaluation (APACHE) II score of > 15 were the independent risk factors identified for thrombocytopenia, The correction of thrombocytopenia mas a protective fatter I educing the risk of mortality in thrombocytopenic patients. Disseminated intravascular coagulation was found in 40% of thrombocytopenic patients, elevated platelet-associated IgG in 33%, and hemophagocytic histiocytes in 67%. Combinations of two of these mechanisms were demonstrated in one quarter of thrombocytopenic patients. Conclusions: Sepsis was the major independent risk factor identified, Thrombocytopenic patients had a higher ICU mortality due to the severity of overall clinical status. Bone man-ow examination could be diagnostic when no obvious causes are demonstrated. Thrombocytopenia probably reflects the severity and course of an underlying pathologic condition, as its correction appears to be a good prognostic factor.
引用
收藏
页码:1363 / 1370
页数:8
相关论文
共 30 条
[1]  
Baglin T, 1996, BMJ-BRIT MED J, V312, P683
[2]   SPLENIC PLATELET-SEQUESTRATION FOLLOWING ROUTINE BLOOD-TRANSFUSION IS REDUCED BY FILTERED WASHED BLOOD PRODUCTS [J].
BAREFORD, D ;
CHANDLER, ST ;
HAWKER, RJ ;
JACKSON, N ;
SMITH, M ;
BOUGHTON, BJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (02) :177-180
[3]   THROMBOCYTOPENIA IN THE INTENSIVE-CARE UNIT [J].
BAUGHMAN, RP ;
LOWER, EE ;
FLESSA, HC ;
TOLLERUD, DJ .
CHEST, 1993, 104 (04) :1243-1247
[4]   THROMBOCYTOPENIA IN THE CRITICALLY ILL PATIENT [J].
BOGDONOFF, DL ;
WILLIAMS, ME ;
STONE, DJ .
JOURNAL OF CRITICAL CARE, 1990, 5 (03) :186-205
[5]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[6]   THROMBOCYTOPENIA IN INTENSIVE-CARE PATIENTS - A COMPREHENSIVE ANALYSIS OF RISK-FACTORS IN 314 PATIENTS [J].
BONFIGLIO, MF ;
TRAEGER, SM ;
KIER, KL ;
MARTIN, BR ;
HULISZ, DT ;
VERBECK, SR .
ANNALS OF PHARMACOTHERAPY, 1995, 29 (09) :835-842
[7]   INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS [J].
BRUNBUISSON, C ;
DOYON, F ;
CARLET, J ;
DELLAMONICA, P ;
GOUIN, F ;
LEPOUTRE, A ;
MERCIER, JC ;
OFFENSTADT, G ;
REGNIER, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :968-974
[8]   INFUSION OF FC-GAMMA-FRAGMENTS FOR TREATMENT OF CHILDREN WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].
DEBRE, M ;
BONNET, MC ;
FRIDMAN, WH ;
CAROSELLA, E ;
PHILIPPE, N ;
REINERT, P ;
VILMER, E ;
KAPLAN, C ;
TEILLAUD, JL ;
GRISCELLI, C .
LANCET, 1993, 342 (8877) :945-949
[9]   Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony-stimulating factor [J].
Francois, B ;
Trimoreau, F ;
Vignon, P ;
Fixe, P ;
Praloran, V ;
Gastinne, H .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (02) :114-120
[10]  
GEORGE JN, 1990, BLOOD, V76, P859